How high resolution FT-IR microscopy is improving tablet formulation across the pharmaceutical industry

CLICK TO LEARN

Analysis of microscopic contamination in pharmaceutical products

Mid-infrared (MIR) microscopy is a useful chemical identification tool that is used to complement traditional light microscopy. Since first coupling an infrared (IR) spectrometer to a microscope, the technique has enjoyed widespread use in a variety of research and industrial applications including the analysis of pharmaceuticals.

In practice, the light microscope is used to locate the region of interest and then it is non-invasively and non-destructively sampled with infrared radiation to provide chemical identification of the desired microscopic area within the sample thus identifying the constituent distribution or any contaminants. 

Comparison of scans from a paracetamol tablet with 5% w/w caffeine (top) and a counterfeit paracetamol tablet adulterated with 5% caffeine (bottom). Red areas represent caffeine distribution. 

With Innovative Thinking,
We Are Changing Things For The Better

Spectrum 3™

Spectrum 3™ Tablet Checker

Spectrum 3™ Accessories

Spotlight 400 FT-IR Microscope  and Spectrum 3™

CLICK TO LEARN

IR microscopy enables the industry to reduce manufacturing cycle times and product variability for shorter time-to-market and with fewer chances of product failures. You can utilize both standard mid-IR attenuated total reflection (ATR) imaging techniques and NIR direct reflectance to gain deeper insights into ingredient distribution in solid doses.

The PerkinElmer Spotlight™ IR microscope systems are designed to meet the challenges of the pharmaceutical industry by generating high-quality, reproducible data from a variety of sample types. The Spotlight 400 FT-IR imaging system combines high sensitivity and rapid imaging with ease-of-use. The ability to image large sample areas rapidly at high spatial resolution extends FT-IR microscopy into new applications. The Spotlight 400 FT-IR imaging system is designed with state-of-the-art technology to allow for intelligent automation and sophisticated analysis. Spotlight and Spectrum FT-IR instruments are 21 CRF 11 compliant and the software and installation services will make meeting regulatory requirements seamless.

CLICK TO LEARN how the Spotlight range of FT-IR Microscopes will help you to deliver better products more quickly.

FOLLOW US 

Go to article: Home | Time for UK plasma to shineGo to article: In this issueGo to article: ContentsGo to article: DatwylerGo to article: LabcorpGo to article: UPS Healthcare Company InsightGo to article: UPS Healthcare Go to article: BaxterGo to article: SHL MedicalGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: PerkinElmerGo to article: CommentGo to article: A new day for Alzheimer’s disease treatmentGo to article: Covid-19 vaccine inequity: the debate over patent waivers intensifiesGo to article: Covid-19 vaccines show efficacy in adolescentsGo to article: International pharmacovigilance for biotechs: forming a strategyGo to article: NiproGo to article: HOF SonderanlagenbauGo to article: MyonexGo to article: In DepthGo to article: Malaria vaccines through the agesGo to article: Are competition authorities tightening the rules on pharma M&A? Go to article: The fishy business of shark squaleneGo to article: Without a trace: can pharma reduce scarring?Go to article: Blood plasma production: OK for the UK?Go to article: When the drugs don’t work: can pharma keep up with mental health?Go to article: The Solubility Company - Company Insight Go to article: The Solubility companyGo to article: Owen Mumford Company InsightGo to article: Owen MumfordGo to article: In DataGo to article: Deals analysisGo to article: The pharma industry key listGo to article: Global markets and indicesGo to article:  Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: EventsGo to article: Next issue